Sign Up to like & get
recommendations!
0
Published in 2018 at "Pharmacological Research"
DOI: 10.1016/j.phrs.2018.07.004
Abstract: ABSTRACT Neurodegenerative diseases (NDs) such as Parkinson's (PD), Alzheimer's (AD), Huntington's disease (HD), and amyotrophic lateral sclerosis (ALS) cause significant world‐wide morbidity and mortality. To date, there is no drug of cure for these, mostly…
read more here.
Keywords:
fatty acids;
omega fatty;
mtors omega;
possible novel ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Blood Advances"
DOI: 10.1182/bloodadvances.2024015132
Abstract: Key Points • LY500307, a selective ERβ agonist, reduces CTCL cell viability with minimal impact on normal skin cells, offering targeted therapy potential.• LY500307 induces apoptosis and G2/M cell cycle arrest in CTCL cells, reducing…
read more here.
Keywords:
receptor stimulation;
estrogen receptor;
stimulation possible;
cell ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2023 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v29.i12.1765
Abstract: Nonalcoholic fatty liver disease (NAFLD) or metabolic-associated fatty liver disease has been characterized by the lipid accumulation with injury of hepatocytes and has become one of the most common chronic liver diseases in the world.…
read more here.
Keywords:
nonalcoholic fatty;
fatty liver;
carnitine palmitoyltransferase;
possible novel ... See more keywords